The North America drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
North America Drug Delivery Systems Market Introduction
The global landscape of drug delivery device research and development (R&D) has witnessed substantial growth over the past few decades, largely propelled by the increasing prevalence of chronic ailments. Drug delivery is defined as the techniques or procedures employed to administer pharmaceutical compounds with the aim of achieving a therapeutic effect in humans. Diverse administration pathways are being explored to effectively manage these persistent health issues. According to figures from the Centers for Disease Control and Prevention (CDC) in 2019, almost 60% of the US population experiences at least one chronic disease, and 40% are affected by two or more. Furthermore, cancer stands as a major contributor to mortality in North America. The American Cancer Society (ACS) estimated approximately 1,735,350 new cancer diagnoses in 2018. A targeted drug delivery system (TDDS) is engineered to release medication in a precisely controlled manner at a specific biological location within the body. Diabetes, a chronic and potentially fatal disease lacking a specific cure, can result in various complications throughout the body and elevate the overall risk of early death across all its forms.
Download our Sample PDF Report
@ https://www.businessmarketinsights.com/sample/TIPRE00005752
North America Drug Delivery Systems Strategic Insights
Strategic insights into the North America Drug Delivery Systems market furnish data-centric evaluations of the industry environment, including present trends, major players, and regional variations. These insights provide actionable recommendations, allowing readers to differentiate themselves from rivals by identifying untapped market segments or creating unique value propositions. By leveraging data analytics, these insights aid industry participants, including investors, manufacturers, and other stakeholders, in anticipating market shifts. Maintaining a forward-looking perspective is vital, enabling stakeholders to foresee market changes and strategically position themselves for sustained success in this dynamic region. In essence, impactful strategic insights empower readers to make well-informed decisions that foster profitability and facilitate the achievement of their business aims within the market.
North America Drug Delivery Systems Market Segmentation
North America Drug Delivery Systems Market: By Route of Administration
- Transmucosal
- Oral
- Injectable
- Topical
- Implantable
- Ocular
North America Drug Delivery Systems Market: By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
North America Drug Delivery Systems Market: By Application
- Home Care Settings
- Hospitals & Clinics
North America Drug Delivery Systems Market: Regions and Countries Covered
North America
- US
- Canada
- Mexico
North America Drug Delivery Systems Market: Market leaders and key company profiles
- BD
- Novo Nordisk A/S
- 3M
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
